These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1693461)

  • 41. Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens.
    Lobato ZI; Coupar BE; Gray CP; Lunt R; Andrew ME
    Vet Immunol Immunopathol; 1997 Nov; 59(3-4):293-309. PubMed ID: 9477479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The crystal structure of bluetongue virus VP7.
    Grimes J; Basak AK; Roy P; Stuart D
    Nature; 1995 Jan; 373(6510):167-70. PubMed ID: 7816101
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of immunogold methodologies for the detection of low copy number viral antigens in bluetongue virus (BTV)-infected cells.
    Hyatt AD; Wise T
    Micron; 1994; 25(6):597-605. PubMed ID: 7881897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of an IGM-specific ELISA for early detection of bluetongue virus infections in domestic ruminants sera.
    Bréard E; Gorlier A; Viarouge C; Donnet F; Sailleau C; Schulz C; Hoffmann B; Comtet L; Beer M; Zientara S; Vitour D
    Transbound Emerg Dis; 2019 Jan; 66(1):537-545. PubMed ID: 30394662
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antigenic profile of African horse sickness virus serotype 4 VP5 and identification of a neutralizing epitope shared with bluetongue virus and epizootic hemorrhagic disease virus.
    Martínez-Torrecuadrada JL; Langeveld JP; Venteo A; Sanz A; Dalsgaard K; Hamilton WD; Meloen RH; Casal JI
    Virology; 1999 May; 257(2):449-59. PubMed ID: 10329555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bluetongue virus characterization.
    Foster NM
    Proc Annu Meet U S Anim Health Assoc; 1975; (79):350-66. PubMed ID: 220625
    [No Abstract]   [Full Text] [Related]  

  • 47. Fine mapping of a continuous epitope on VP7 of bluetongue virus using overlapping synthetic peptides and a random epitope library.
    du Plessis DH; Wang LF; Jordaan FA; Eaton BT
    Virology; 1994 Jan; 198(1):346-9. PubMed ID: 7505073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional dissection of the major structural protein of bluetongue virus: identification of key residues within VP7 essential for capsid assembly.
    Limn CK; Staeuber N; Monastyrskaya K; Gouet P; Roy P
    J Virol; 2000 Sep; 74(18):8658-69. PubMed ID: 10954567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bluetongue virus infection of bovine monocytes.
    Whetter LE; Maclachlan NJ; Gebhard DH; Heidner HW; Moore PF
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1663-76. PubMed ID: 2544659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An atomic model of the outer layer of the bluetongue virus core derived from X-ray crystallography and electron cryomicroscopy.
    Grimes JM; Jakana J; Ghosh M; Basak AK; Roy P; Chiu W; Stuart DI; Prasad BV
    Structure; 1997 Jul; 5(7):885-93. PubMed ID: 9261080
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of four distinct neutralizing epitopes on bluetongue virus serotype 10 using neutralizing monoclonal antibodies and neutralization-escape variants.
    Heidner HW; Rossitto PV; MacLachlan NJ
    Virology; 1990 Jun; 176(2):658-61. PubMed ID: 1693250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Competitive ELISA for serodiagnosis of bluetongue: evaluation of group-specific monoclonal antibodies and expressed VP7 antigen.
    Afshar A; Eaton BT; Wright PF; Pearson JE; Anderson J; Jeggo M; Trotter HC
    J Vet Diagn Invest; 1992 Jul; 4(3):231-7. PubMed ID: 1325189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cross-neutralization of genetic reassortants of bluetongue virus serotypes 20 and 21.
    Cowley JA; Gorman BM
    Vet Microbiol; 1989 Jan; 19(1):37-51. PubMed ID: 2466366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High level expression of the major core protein VP7 and the non-structural protein NS3 of bluetongue virus in yeast: use of expressed VP7 as a diagnostic, group-reactive antigen in a blocking ELISA.
    Martyn JC; Gould AR; Eaton BT
    Virus Res; 1991 Mar; 18(2-3):165-78. PubMed ID: 1645903
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the genes encoding two of the major capsid proteins of epizootic haemorrhagic disease virus indicates a close genetic relationship to bluetongue virus.
    Iwata H; Chuma T; Roy P
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():915-24. PubMed ID: 1321879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation of Recombinant Modified Vaccinia Virus Ankara Encoding VP2, NS1, and VP7 Proteins of Bluetongue Virus.
    Marín-López A; Ortego J
    Methods Mol Biol; 2016; 1349():137-50. PubMed ID: 26458834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and localization of a serotypic neutralization determinant on the VP2 protein of bluetongue virus 13.
    Hwang GY; Li JK
    Virology; 1993 Aug; 195(2):859-62. PubMed ID: 7687805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fine mapping of a surface-accessible, immunodominant site on the bluetongue virus major core protein VP7.
    Wang LF; Scanlon DB; Kattenbelt JA; Mecham JO; Eaton BT
    Virology; 1994 Nov; 204(2):811-4. PubMed ID: 7941351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantification of recombinant core-like particles of bluetongue virus using immunosorbent electron microscopy.
    Zheng YZ; Hyatt A; Wang LF; Eaton BT; Greenfield PF; Reid S
    J Virol Methods; 1999 Jun; 80(1):1-9. PubMed ID: 10403670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2.
    Feenstra F; Pap JS; van Rijn PA
    Vaccine; 2015 Feb; 33(6):812-8. PubMed ID: 25510389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.